Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for QCLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 22.87M
March 31, 2026 38.29M
December 31, 2025 41.17M
September 30, 2025 37.23M
June 30, 2025 17.15M
March 31, 2025 18.78M
December 31, 2024 21.42M
September 30, 2024 24.04M
June 30, 2024 26.38M
March 31, 2024 14.49M
December 31, 2023 17.86M
September 30, 2023 21.83M
June 30, 2023 25.25M
March 31, 2023 28.41M
December 31, 2022 17.54M
September 30, 2022 20.23M
June 30, 2022 19.16M
March 31, 2022 22.20M
December 31, 2021 24.81M
September 30, 2021 28.01M
June 30, 2021 34.45M
March 31, 2021 35.80M
December 31, 2020 36.84M
September 30, 2020 23.72M
June 30, 2020 18.68M
Date Value
March 31, 2020
December 31, 2019 10.88M
September 30, 2019 4.971M
June 30, 2019 5.932M
March 31, 2019 7.042M
December 31, 2018 7.807M
September 30, 2018 10.02M
June 30, 2018 12.65M
March 31, 2018 12.80M
December 31, 2017 9.338M
September 30, 2017 5.466M
June 30, 2017 6.500M
March 31, 2017 7.106M
December 31, 2016 5.085M
September 30, 2016 5.780M
June 30, 2016 5.684M
March 31, 2016 6.654M
December 31, 2015 8.272M
September 30, 2015 11.05M
June 30, 2015 13.28M
March 31, 2015 15.36M
December 31, 2014 16.65M
September 30, 2014 16.78M
June 30, 2014 17.77M
March 31, 2014 17.78M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Johnson & Johnson 201.06B
Eli Lilly & Co. 142.28B

Total Assets (Quarterly) Related Metrics